nonprofit logo

Fred Hutchinson Cancer Research Center

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 237156071 ✦ Seattle, WA ✦ Designated as a 501(c)(3)

Overview

What is Fred Hutchinson Cancer Research Center?

Fred Hutchinson Cancer Research Center is a leading scientific research institute based in Seattle, Washington, with a workforce of approximately 3700 employees. Their mission is to drive discovery and make a positive impact on the world by pushing the boundaries of human knowledge in cancer and HIV research. The Vaccine and Infectious Disease Division (VIDD) at Fred Hutch integrates computational, laboratory, and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Researchers at Fred Hutch collaborate with scientists from various laboratories, clinical sites, and field sites in the Americas, Africa, Asia, and Europe, focusing on infection-related cancers and diseases that affect high-risk populations in these regions. The division is actively engaged in initiatives in Uganda, China, and the Republic of South Africa. Their collaborative efforts aim to predict, detect, treat, and prevent infectious diseases in humans, including known and emerging infections of major global health importance, such as coronavirus and cancer-related infectious diseases.


Official website here: www.fredhutch.org/en.html

Is Fred Hutchinson Cancer Research Center legitimate?

Fred Hutchinson Cancer Research Center is a legitimate nonprofit organization registered as a 501(c)(3) entity. Fred Hutchinson Cancer Research Center submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $15,334,946
Professional Fundraising Fees: $1,562,759
Other Salaries and Wages: $192,242,585

For more financial information, click here


Official website here: www.fredhutch.org/en.html

What is the mission statement of Fred Hutchinson Cancer Research Center?

The Fred Hutchinson Cancer Research Center is at the forefront of scientific research in cancer and HIV, pushing the boundaries of human knowledge. Their team of researchers are dedicated to leading the way towards a world free of cancer and related diseases through fearless science, collaboration, and unwavering focus. The center's Vaccine and Infectious Disease Division integrates the latest research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Researchers collaborate with scientists worldwide to predict, detect, treat, and prevent infectious diseases in humans, including known and emerging infections of global health significance, such as coronavirus and cancer-related infectious diseases. Through their collaborative efforts, they strive to predict, detect, treat, and prevent infectious diseases in humans.


Official website here: www.fredhutch.org/en.html

Who is the CEO of Fred Hutchinson Cancer Research Center?

Dr Thomas Lynch Jr is the Principal Officer of Fred Hutchinson Cancer Research Center.


Official website here: www.fredhutch.org/en.html

What is the revenue of Fred Hutchinson Cancer Research Center?

Fred Hutchinson Cancer Research Center's revenue in 2022 was $696,845,474.


Official website here: www.fredhutch.org/en.html

Who are the executives of Fred Hutchinson Cancer Research Center and what are their salaries?

The average compensation at Fred Hutchinson Cancer Research Center during 2022 was $55,785. There are 3,721 employees and 800 volunteers at Fred Hutchinson Cancer Research Center.

Here are 55 key members and their salaries:

    Thomas James Lynch Jr (President & Director)
  • Compensation: $1,702,109
  • Related: $0
  • Other: $66,608

    • Nancy E Davidson (Sr. Vp & Director, Crd)
  • Compensation: $1,266,466
  • Related: $0
  • Other: $47,218

    • Steve Stadum (Spec Advisor)
  • Compensation: $1,132,208
  • Related: $0
  • Other: $56,974

    • David Harlan Browdy (Vp & Chief Financial Officer)
  • Compensation: $853,047
  • Related: $0
  • Other: $61,264

    • Nicole C Robinson (Vp & Chief Operating Officer)
  • Compensation: $849,608
  • Related: $0
  • Other: $53,518

    • Eric C Holland (Sr Vp & Dir, Human Biology)
  • Compensation: $776,770
  • Related: $0
  • Other: $53,518

    • Bruce E Clurman (Exec Vp & Deputy Dir, Fhcrc)
  • Compensation: $767,846
  • Related: $0
  • Other: $56,974

    • Frederick R Appelbaum (Exec Vp & Deputy Director)
  • Compensation: $758,585
  • Related: $0
  • Other: $55,623

    • Steven Haydon (Vp, General Counsel)
  • Compensation: $585,496
  • Related: $0
  • Other: $56,827

    • Kelly O'Brien (Vice President, Philanthropy)
  • Compensation: $515,402
  • Related: $0
  • Other: $56,339

    • Margaret Juliana Mcelrath (Sr Vp & Director - Vidd)
  • Compensation: $491,059
  • Related: $0
  • Other: $46,432

    • Marion S Dorer (Vp, Interdisciplinary Sci Adm)
  • Compensation: $478,101
  • Related: $0
  • Other: $47,124

    • Jodi Lorraine Burke (Vp Human Resources)
  • Compensation: $464,479
  • Related: $0
  • Other: $51,497

    • Peter S Nelson (Full Professor)
  • Compensation: $449,036
  • Related: $0
  • Other: $60,222

    • Geoffrey R Hill (Sr Vp & Dir Bgi)
  • Compensation: $450,843
  • Related: $0
  • Other: $55,890

    • Garnet L Anderson (Sr Vp & Dir, Phs)
  • Compensation: $412,815
  • Related: $0
  • Other: $47,100

    • Jerald Patrick Radich (Full Professor)
  • Compensation: $396,440
  • Related: $0
  • Other: $59,736

    • Stanley R Riddell (Full Professor)
  • Compensation: $394,966
  • Related: $0
  • Other: $55,733

    • Christopher Li (Vp, Faculty Affair & Diversity)
  • Compensation: $370,933
  • Related: $0
  • Other: $59,646

    • Stephanie J Lee (Full Professor)
  • Compensation: $390,143
  • Related: $0
  • Other: $38,001

    • Jennifer E Griffith (Vp Gov'T & Community Relations)
  • Compensation: $368,396
  • Related: $0
  • Other: $46,834

    • Kathy L Alexion (Vp & Chief Information Officer)
  • Compensation: $321,053
  • Related: $0
  • Other: $35,200

    • Paul M Buckley (Vp & Chief Divers/Incl Officer)
  • Compensation: $293,316
  • Related: $0
  • Other: $44,681

    • Elizabeth Boyd (Vp, Res Adm & Faculty Affairs)
  • Compensation: $276,810
  • Related: $0
  • Other: $42,625

    • Chris Bundesmann (Corporate Controller)
  • Compensation: $269,599
  • Related: $0
  • Other: $43,862

    • Jonathan A Cooper (Sr Vp & Dir, Basic Sciences)
  • Compensation: $262,229
  • Related: $0
  • Other: $43,876

    • Herbert L Bone Iii (Corporate Treasurer)
  • Compensation: $231,853
  • Related: $0
  • Other: $44,129

    • D Gary Gilliland (President & Director Emeritus)
  • Compensation: $168,188
  • Related: $0
  • Other: $0

    • Val Rie J Smith (Assistant To The Board Of Trustees)
  • Compensation: $117,182
  • Related: $0
  • Other: $18,078

    • Susan Biggins (Sr Vp & Dir, Basic Sciences)
  • Compensation: $112,819
  • Related: $0
  • Other: $0

    • Scott N Rusch (Vp, Facilities & Operations)
  • Compensation: $3,085
  • Related: $0
  • Other: $0

    • Kathy Surace-Smith (Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Leigh Morgan (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sean Boyle (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Richard W Anderson (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Carl Behnke (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael Clayville (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Hollis S Dillon (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mark Fleischauer (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Theresa Gillespie (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Stephen M Graham (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Christine Gregoire (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Herbold (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Allan Jones (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Philip Kent (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Connie Kravas (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Matthew Mcilwain (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Norman Metcalfe (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Satya Nadella (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paul W Reed (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Brian Roberts (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Corazon Sanders (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Pete Shimer (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bryan White (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kelly Patrick (Vp, Chief Information Officer)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.fredhutch.org/en.html

    Where can I find the form 990 for Fred Hutchinson Cancer Research Center?

    The Fred Hutchinson Cancer Research Center’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.fredhutch.org/en.html

    Learn more at the official website: www.fredhutch.org/en.html

    Mission Statement of Fred Hutchinson Cancer Research Center

    Fred Hutchinson Cancer Research Center (FRED HUTCH) is a pioneering institution in the realm of scientific research, primarily focusing on cancer and HIV. With a relentless pursuit of knowledge, its researchers are pushing the boundaries of human understanding, from fundamental biology to population-level health. Through fearless science, interdisciplinary collaboration, and unwavering focus, FRED HUTCH is spearheading the way towards a world devoid of cancer and related diseases.

    The Vaccine and Infectious Disease Division (VIDD) at FRED HUTCH integrates cutting-edge computational, laboratory, and clinical research methods to advance the study of microbial pathogenesis and infectious disease processes. Researchers at VIDD collaborate with scientists from various disciplines and locations around the world, including the Americas, Africa, Asia, and Europe. The division boasts specific initiatives in Uganda, China, and the Republic of South Africa to expand the comprehension of infection-related cancers and infectious diseases that disproportionately affect high-risk populations in these regions. VIDD scientists, consisting of clinicians, clinical trial specialists, statisticians, computational biologists, and basic scientists, take pride in their collaborative efforts to predict, detect, treat, and prevent infectious diseases in humans. Their work encompasses well-known and emerging infections of significant global health importance, such as coronavirus, as well as cancer-related infectious diseases.

    Impact

    This information is meant to be a general summary of Fred Hutchinson Cancer Research Center. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Fred Hutchinson Cancer Research Center is at the forefront of scientific research in cancer and HIV, driving discovery to make the world a better place. Their Vaccine and Infectious Disease Division integrates cutting-edge computational, laboratory, and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Researchers at the center partner with scientists globally to tackle infectious diseases that affect high-risk populations in various regions, including initiatives in Uganda, China, and South Africa.

    The impact of Fred Hutchinson Cancer Research Center extends beyond its research efforts. Through fearless science, collaboration across disciplines, and unwavering focus, the center is leading the way towards a world free of cancer and related diseases. Their work is expanding human knowledge from foundational biology to population-level health, making significant strides in the fight against cancer and infectious diseases of global health importance, such as coronavirus. Fred Hutchinson Cancer Research Center's relentless pursuit of solutions is shaping the future of healthcare and positively impacting communities worldwide.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $89,242,611
  • Program Service Revenue: $56,158,707
  • Gross Receipts: $696,870,035

    • Assets and Liabilities:
  • Total Assets: $0
  • Total Liabilities: $0
  • Net Assets: $0
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    INTERAFFILIATE AGMTS

    Revenue

    $29,383,938

    PATIENT SVCS AT SCCA

    Revenue

    $20,346,400

    RESEARCH ACTIVITIES

    Revenue

    $8,855,036

    SCCA INVESTMENT INCOME

    Revenue

    $-2,426,667

    Organization Details

    Founding Year

    1971

    Principal Officer

    Dr Thomas Lynch Jr

    Main Address

    1100 FAIRVIEW AVENUE NORTH, SEATTLE, WA, 981091024

    NTEE Category

    Code: H30 - Medical research

    If you are a representative of Fred Hutchinson Cancer Research Center and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.